- Home
- Publications
- Publication Search
- Publication Details
Title
Lupus nephritis: new progress in diagnosis and treatment
Authors
Keywords
-
Journal
JOURNAL OF AUTOIMMUNITY
Volume -, Issue -, Pages 102871
Publisher
Elsevier BV
Online
2022-08-20
DOI
10.1016/j.jaut.2022.102871
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
- (2022) Richard A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
- (2022) David Jayne et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
- (2022) Ioannis Parodis et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
- (2022) Yudong Liu et al. JOURNAL OF RHEUMATOLOGY
- B Cell Aberrance in Lupus: the Ringleader and the Solution
- (2021) YuXue Nie et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
- (2021) Juan M. Mejía-Vilet et al. Frontiers in Medicine
- Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside
- (2021) Bogdan Obrișcă et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- (2021) Brad H Rovin et al. LANCET
- Gut Microbiota in Lupus: a Butterfly Effect?
- (2021) Rongli Li et al. Current Rheumatology Reports
- Glutathione peroxidase 4–regulated neutrophil ferroptosis induces systemic autoimmunity
- (2021) Pengchong Li et al. NATURE IMMUNOLOGY
- The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
- (2021) Feliciano Chanana Paquissi et al. Frontiers in Medicine
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
- (2021) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Urine Proteomics and Renal Single Cell Transcriptomics Implicate IL ‐16 in Lupus Nephritis
- (2021) Andrea Fava et al. Arthritis & Rheumatology
- Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis.
- (2020) Yogesh Scindia et al. KIDNEY INTERNATIONAL
- Lupus nephritis
- (2020) Hans-Joachim Anders et al. Nature Reviews Disease Primers
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis
- (2020) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development
- (2020) Min Wang et al. JOURNAL OF AUTOIMMUNITY
- Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
- (2020) Lorenza Maria Argolini et al. JOURNAL OF NEPHROLOGY
- Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis
- (2020) Juan M. Mejia-Vilet et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
- (2020) Samantha Stanley et al. Nature Communications
- Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis
- (2020) Kamala Vanarsa et al. ANNALS OF THE RHEUMATIC DISEASES
- Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications
- (2020) Yin Zhao et al. JOURNAL OF AUTOIMMUNITY
- What is the value of repeat kidney biopsies in patients with lupus nephritis?
- (2020) Enrique Morales et al. LUPUS
- Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials
- (2020) Yoshiya Tanaka et al. Modern Rheumatology
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus
- (2020) Xianyong Yin et al. ANNALS OF THE RHEUMATIC DISEASES
- Cellular aspects of the pathogenesis of lupus nephritis
- (2020) Anthony Chang et al. CURRENT OPINION IN RHEUMATOLOGY
- The Type II anti‐CD20 Antibody Obinutuzumab (GA101) is More Effective than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model
- (2020) Anthony D. Marinov et al. Arthritis & Rheumatology
- IL-12 and IL-23/Th17 axis in systemic lupus erythematosus
- (2019) Maddalena Larosa et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Clinical efficacy and safety of rituximab in lupus nephritis
- (2019) Zhiqing Zhong et al. Drug Design Development and Therapy
- Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation
- (2019) Chaohuan Guo et al. JOURNAL OF AUTOIMMUNITY
- Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients
- (2019) Huang Dedong et al. IMMUNOLOGY LETTERS
- ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions
- (2019) Ann-Helen Willrodt et al. Frontiers in Immunology
- Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
- (2019) Julien Zuber et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- T cell–specific STAT3 deficiency abrogates lupus nephritis
- (2019) N Yoshida et al. LUPUS
- Lupus Podocytopathy: An Overview
- (2019) Nestor Oliva-Damaso et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- A tale of two antibodies: obinutuzumab versus rituximab
- (2018) Ciara L. Freeman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
- (2018) Ingeborg M. Bajema et al. KIDNEY INTERNATIONAL
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab
- (2018) Y Satoh et al. LUPUS
- Mechanisms of Tissue Injury in Lupus Nephritis
- (2018) Giovanna Flores-Mendoza et al. TRENDS IN MOLECULAR MEDICINE
- Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease
- (2018) Sanne van Raaij et al. Scientific Reports
- Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis
- (2018) Yuan-yuan Qi et al. ANNALS OF THE RHEUMATIC DISEASES
- Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis
- (2018) Liliana Michelle Gomez Mendez et al. Clinical Journal of the American Society of Nephrology
- A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy
- (2018) Marcelo De Rosa et al. KIDNEY INTERNATIONAL
- Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center
- (2018) Kazunori Karasawa et al. RHEUMATOLOGY INTERNATIONAL
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Multitarget Therapy for Maintenance Treatment of Lupus Nephritis
- (2017) Haitao Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The value of repeat biopsy in lupus nephritis flares
- (2017) Javier Narváez et al. MEDICINE
- Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
- (2017) Feng Yu et al. Nature Reviews Nephrology
- Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence
- (2017) Savino Sciascia et al. RHEUMATOLOGY INTERNATIONAL
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria
- (2017) Eileen S. Marks et al. Scientific Reports
- Tacrolimus use in lupus nephritis: A systematic review and meta-analysis
- (2016) Jennifer Hannah et al. AUTOIMMUNITY REVIEWS
- Update on Lupus Nephritis
- (2016) Salem Almaani et al. Clinical Journal of the American Society of Nephrology
- Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis
- (2016) Nobuhide Endo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Multitarget Therapy for Induction Treatment of Lupus Nephritis
- (2015) Zhihong Liu et al. ANNALS OF INTERNAL MEDICINE
- Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
- (2015) T. R. W. Tipton et al. BLOOD
- B Cells, Antibodies, and More
- (2015) W. Hoffman et al. Clinical Journal of the American Society of Nephrology
- Mycophenolate mofetil for lupus nephritis: an update
- (2015) Chi Chiu Mok Expert Review of Clinical Immunology
- Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
- (2015) Yoshiya Tanaka et al. Modern Rheumatology
- Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis
- (2015) Chandra Mohan et al. Nature Reviews Nephrology
- What is damaging the kidney in lupus nephritis?
- (2015) Anne Davidson Nature Reviews Rheumatology
- The Complement System in Lupus Nephritis
- (2015) Daniel J. Birmingham et al. SEMINARS IN NEPHROLOGY
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
- (2014) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Kidney Pericytes: Roles in Regeneration and Fibrosis
- (2014) Rafael Kramann et al. SEMINARS IN NEPHROLOGY
- Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study
- (2014) Arthritis & Rheumatology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Reactive Oxygen Species in Inflammation and Tissue Injury
- (2013) Manish Mittal et al. ANTIOXIDANTS & REDOX SIGNALING
- Prednisone in lupus nephritis: How much is enough?
- (2013) Guillermo Ruiz-Irastorza et al. AUTOIMMUNITY REVIEWS
- The Pathogenesis of Lupus Nephritis
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials
- (2012) Lorna K. Henderson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Lupus Nephritis: Induction Therapy in Severe Lupus Nephritis--Should MMF Be Considered the Drug of Choice?
- (2012) B. H. Rovin et al. Clinical Journal of the American Society of Nephrology
- Activation of pericytes
- (2012) Cécile Fligny et al. CURRENT OPINION IN RHEUMATOLOGY
- Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial
- (2012) W Chen et al. LUPUS
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis
- (2012) Y Yin et al. LUPUS
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis
- (2012) Sandeep Singh et al. ARTHRITIS RESEARCH & THERAPY
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Segmental and Global Subclasses of Class IV Lupus Nephritis Have Similar Renal Outcomes
- (2011) C. M. Haring et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The type I interferon system in the development of lupus
- (2011) Lars Rönnblom et al. SEMINARS IN IMMUNOLOGY
- Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
- (2010) Wei Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
- (2010) E. Mossner et al. BLOOD
- In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
- (2010) A. Chang et al. JOURNAL OF IMMUNOLOGY
- Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system
- (2010) Feng Yu et al. KIDNEY INTERNATIONAL
- Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis
- (2010) Nanticha Kamanamool et al. MEDICINE
- TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
- (2010) Cristiana Guiducci et al. NATURE
- The podocyte as a direct target of immunosuppressive agents
- (2010) E. Schonenberger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
- (2009) F A Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Development of TLR inhibitors for the treatment of autoimmune diseases
- (2008) Franck J. Barrat et al. IMMUNOLOGICAL REVIEWS
- Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
- (2008) H. Bao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice
- (2008) SL Lui et al. LUPUS
- The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
- (2008) Christian Faul et al. NATURE MEDICINE
- Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
- (2008) I. Neumann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genomic and nongenomic effects of glucocorticoids
- (2008) Cindy Stahn et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search